Seminal peroxidase positive cells are not an adequate indicator of asymptomatic urethral genital infection

The relationship between asymptomatic urethral infection and seminal white blood cells, as detected using the peroxidase enzyme system, was examined. Eighty-four semen donors were tested. Twenty-four (29%) were diagnosed as having an active urethral genital infection. There was no statistical relationship between the total number of concentrations of peroxidase-positive cells and a urethral genital infection. Further studies should concentrate on the subtypes of seminal leucocytes and their surface receptors using monoclonal antibodies.     

256例性病门诊患者安全性行为调查分析

目的:了解性病患者对安全性行为知识的知晓情况。方法:采用问卷方式对256例性病门诊患者进行安全套问题调查,并对所得数据进行统计分析。结果:从不使用安全套患者由初诊117例(45.7%)降到复诊时86例(33.6%);得知自己患性病后不用安全套与他人性交初诊118例(46.1%)下降到复诊时97例(37%);不用安全套与无性病症状的人性交会否感染性病回答不知道的由初诊58例(22.7%)下降到复诊时14例(5.5%)。结论:加大提倡使用安全套的宣传力度,提高人们对安全性行为的认识水平,提高安全套的使用率,是控制和预防性病及爱滋病经性接触传播流行的关键。     

配合尿道灌注治疗男性支原体性尿道炎

目的 观察配合尿道灌注治疗男性支原体性尿道炎的疗效。方法 将530例患者随机分为4组。A组：尿道灌注组；B组：静脉给药组；C组：上述两种方法并用；D组：C组的基础上，加用紫苓胶囊。结果 A组与B组间总有效率差异无显著性（P〉0．05）；C组与D组总有效率高于A组与B组（P〈0．05）；C组与D组间总有效率差异无显著性（P〉0．05），在复查支原体阴性患者中，D组治愈率高于C组（P〈0．05）。结论 阿奇霉素尿道灌注与静点疗效相同，联合用药可提高疗效，紫苓胶囊可以改善不适症状。     

Sexually transmitted diseases in Bauchi,Nigeria

Sexually transmitted diseases pose a health threat to families, society and the nation but there is no report of these diseases to help health planners in Bauchi. Medical records were examined from 1983 to 1988 in two major health institutions, the University Medical Centre and the Specialist Hospital to determine the extent and types of these diseases in Bauchi.

Urethritis, syphilis, candidiasis, pelvic inflammatory diseases, trichomoniasis were very common. Gonorrhoea was the least reported disease.

The cases of syphilis reported at the Specialist Hospital nearly doubled from 111 in 1983 to 214 in 1988, urethritis increased from 141 to 232. In the University Medical Centre, all reported cases of sexually transmitted diseases decreased from 1983 to 1988.

Data analysis of cases common to the Specialist Hospital and the University Medical Centre gave no significant difference between the institutions at the 95% level of confidence.     

Human leukocyte interferon-α in cream,for the treatment of genital warts in asian women a placebo-controlled,double-blind study

The purpose of this double-blind, placebo-controlled study was to determine and compare the clinical efficacy and tolerance of human leukocyte -interferon (incorporated 2 × 10⁶ IU/g) in hydrophilic cream to cure genital warts. Preselected Asian female patients (n=150) aged 18–40 years (mean 22.5), with the clinical and biopsy-confirmed diagnosis of genital warts (mean 2.64), predominantly flat vaginal condylomas, were randomly allocated to 3 parallel groups. Each patient was given a coded tube containing 80 g placebo/active preparation with a graduated applicator. Patients were instructed to inject 6 g of the either alloted placebo/active cream deep into the vagina thrice a day for 3 consecutive days (group A) or 4 consecutive days (group B) per week, and if not cured the same treatment was extended to 3 more weeks (maximum 4 weeks active treatment). To assess the clinical efficacy patients were examined on a week-to-week basis. A total clearance of warts (biopsy-confirmed) was evaluated as a complete cure. Patients cured during the treatment were spared further treatment and were requested to visit us after 16 weeks for relapse control. As for the remaining patients, empty tubes were collected, and similarly coded replacement tubes were given for further treatment (in total 588 tubes were used). By the end of the treatment 57.2% lesions (227/397) were eliminated in all the groups: 48% patients in group A, 90% patients in group B, and 10% patients in placebo groups taken as completely cured. Of the 150 patients 128 (85.3%) did not complain of any drug-related adverse symptoms. Transitory increase in body temperature (mean 38.4°C), accompanied by headache (14.6%) and generalized itching (6.6%) were the most frequently reported side effects; however, treatment was well tolerated by all the patients, and there were no dropouts. Our findings indicate that clinical efficacy is dose dependent, that is, the results of group B were significantly superior to that of group A (P < 0.05). Of the 49.3% cured patients (74/150) followed up for 6 months (monthly basis) seven had a relapse, and none had reinfection. It is concluded that clinical efficacy of leukocyte interferon-a to cure genital warts is dose dependent. These results further support the view that leukocyte interferon-a incorporated in hydrophilic cream can be considered a reliable, safe, and home-based treatment to cure vulvar and vaginal warts.Abbreviation HPV human papillomavirus     

聚维酮碘液尿道灌注治疗慢性尿道炎合并前列腺炎

目的 :探讨 0 .5 %聚维酮碘 (PVP I)液保留尿道灌注治疗慢性尿道炎合并前列腺炎的临床疗效。方法 :将门诊慢性尿道炎合并前列腺炎患者随机分为 2组 ,治疗组 38例采用 0 .5 %PVP I液尿道灌注+口服美满霉素治疗 ,对照组 4 2例单纯口服美满霉素治疗 ,为期 2wk ,比较治疗效果。结果 :治疗组与对照组比较 ,治愈率和总有效率均有统计学意义 (P<0 .0 1)。结论 :0 .5 %PVP I液尿道灌注配合抗生素治疗慢性尿道炎合并前列腺炎的疗效高于对照组 ,可显著提高治愈率和总有效率 ,且无明显并发症 ,费用低。     

4种方案治疗非淋菌性尿道（宫颈）炎的成本—效果分析

目的 :探讨不同抗感染药治疗方案对同一疾病所产生的经济效果。方法 :将 2 5 4例非淋菌性尿道 (宫颈 )炎患者随机分成4组 ,分别给予阿齐霉素 (希舒美 ) (A组 )、阿齐霉素 (尤尼克 ) (B组 )、罗红霉素 (C组 )、左氧氟沙星 (D组 )治疗 ,运用药物经济学的成本 -效果分析法进行评价。结果 :4种方案的成本依次为 6 6 4 0、38 0 0、39 90、95 2 0元 ,治愈率分别为 88 0 6 %、82 81%、73 0 2 %、78 33%。结论 :B方案为最佳治疗方案。     

2003～2004年南昌市泌尿生殖道支原体的耐药分析

目的了解南昌地区STD门诊患者泌尿生殖道支原体感染及耐药情况，为临床治疗提供参考依据。方法应用法国生物梅里埃公司的IST2试剂盒进行支原体培养＋药敏检测：结果原始霉素（95.5％）、交沙霉素（91．8％）、强儿霉素（90％）、四环素（81．9％）对Uu的敏感性很强，其次是克拉毒素（63．9％）。阿奇毒素为常用抗生素，但敏感半仅为（42．4％），而氧氟沙星（10．8％）和环丙沙星（1．8％）对Uu的敏感性相对较低：结论原始霉素、交沙霉素、强力霉素、四环素等应作为本地区目前治疗泌尿生殖道支原体感染的首选抗生素。     

非淋菌性尿道炎合并盆腔感染药物治疗效果对比研究

目的探讨临床上对非淋菌性尿道(宫颈)炎合并盆腔感染有效的治疗方法。方法将妇产科及性病科门诊确诊的非淋菌性尿道(宫颈)炎合并盆腔感染201例病人随机分为2组,治疗组采用头孢曲松纳加阿奇霉素治疗,对照组采用头孢曲松纳加口服美满霉素治疗。结果治疗组治愈率为80.95%,总有效率为97.14%;对照组治愈率为58.33%,总有效率为69.79%。两者的,临床治愈率及有效率有显著性的差异(P<0.005)。结论头孢曲松纳加阿奇霉素静脉给药治疗非淋菌性尿道(宫颈)炎合并盆腔感染取得良好的治疗效果,较头孢曲松纳加美满霉素效果有显著性提高。     

泌尿生殖系统支原体检测及药敏分析

目的:了解本地区非淋菌性泌尿生殖系统支原体感染及药敏情况,为临床治疗提供依据,以提高疗效。方法:采用法国生物—梅里埃公司生产的支原体试剂盒对588例泌尿生殖道感染患者的泌尿生殖道标本进行支原体培养、鉴定及药敏分析。结果:588例泌尿道患者支原体培养阳性率为35.26％(206/588),其中解脲支原体(Uu)感染阳性率为27.85％(157/588),人型支原体(Mh)感染阳性率为3.35％(22/588),Uu-+Mh混合感染阳性率为4.06％(27/588),解脲支原体感染显著高于人型支原体及混合感染(P<0.01)。男女Uu感染阳性率分别为13.83％(30/286)和42.06％(127/302),有显著性差异(P<0.01),女性感染率明显高于男性。对8种抗生素的药敏试验结果为交沙霉素抑菌能力最强,以下依次为原始霉素、克拉霉素、强力霉素、美满霉素、阿奇霉素、罗红霉素、司帕霉素。结论:非淋菌性泌尿生殖道感染由支原体感染引起者呈逐渐上升趋势,其中以女性患者居多,临床治疗可根据药敏试验结果选择药物,以减少盲目性和耐药性。